Metabolic & Weight Health
Clinical Intelligence Hub • Expert Curation
Metabolic health and clinician-guided weight management are critical drivers of biological age. We review historical and recent breakthroughs in GLP-1/GIP receptor agonists (like semaglutide and tirzepatide), NAD+ precursors, and mitochondrial energy optimization. Restoring metabolic fitness mitigates systemic inflammation and promotes cellular repair.
Discover how rare genetic variants in the MSTN and FNIP1 genes help prevent GLP-1 muscle loss and naturally optimize metabolic health and body composition.
New research reveals that glucagon receptor signaling is essential for the lifespan and metabolic benefits of caloric restriction in aging models.
This landmark study using partitioned polygenic scores reveals how specific Type 2 diabetes genetic risk pathways influence different hallmarks of aging.
Explore how oral GLP-1 weight loss options perform in clinical trials, and discover the essential strategies to manage peptide side effects during therapy.
A prospective study reveals how oral semaglutide body composition changes occur, reducing body fat and salt intake while preserving skeletal muscle mass.
Do GLP-1 physical performance enhancers alter athletic capacity? Explore incretin pharmacology, metabolic biomarkers, and anti-doping sports regulations.
Evaluating how GLP-1 receptor agonists alter adipocyte biology and adipose-derived stem cells, potentially impacting autologous fat graft survival rates.
Are GLP-1 drugs safe for patients managing epilepsy, obesity, and diabetes? Learn how these metabolic therapies impact seizure control and weight loss.
Discover how precision amino acid tuning through methionine restriction optimizes metabolic health and prevents age-related physical frailty.